PriceTargets.com logo

Tristel - TSTL Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 390
  • Forecasted Upside: -12.95%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 448 As of 04/19/2024 02:39 PM ET
▼ -17 (-3.66%)

This chart shows the closing price for TSTL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tristel Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TSTL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TSTL

Analyst Price Target is GBX 390
▼ -12.95% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Tristel in the last 3 months. The average price target is GBX 390, with a high forecast of GBX 390 and a low forecast of GBX 390. The average price target represents a -12.95% upside from the last price of GBX 448.

This chart shows the closing price for TSTL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Tristel. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/25/2023Numis SecuritiesInitiated CoverageAddGBX 390
7/22/2020FinnCapReiterated RatingCorporate
3/23/2020FinnCapReiterated RatingCorporate
2/24/2020FinnCapReiterated RatingCorporate
12/17/2019FinnCapReiterated RatingCorporate
10/16/2019FinnCapReiterated RatingCorporate
7/22/2019FinnCapReiterated RatingCorporate
(Data available from 4/19/2019 forward)

News Sentiment Rating

1.30 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Tristel logo
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Read More

Today's Range

Now: GBX 448
Low: 440
High: 460.40

50 Day Range

MA: GBX 460.61
Low: 435
High: 490

52 Week Range

Now: GBX 448
Low: 315
High: 503.50

Volume

38,539 shs

Average Volume

55,934 shs

Market Capitalization

£212.76 million

P/E Ratio

3,446.15

Dividend Yield

2.73%

Beta

0.28

Frequently Asked Questions

What sell-side analysts currently cover shares of Tristel?

The following sell-side analysts have issued reports on Tristel in the last twelve months: Numis Securities Ltd.
View the latest analyst ratings for TSTL.

What is the current price target for Tristel?

1 Wall Street analysts have set twelve-month price targets for Tristel in the last year. Their average twelve-month price target is GBX 390, suggesting a possible downside of 12.9%. Numis Securities Ltd has the highest price target set, predicting TSTL will reach GBX 390 in the next twelve months. Numis Securities Ltd has the lowest price target set, forecasting a price of GBX 390 for Tristel in the next year.
View the latest price targets for TSTL.

What is the current consensus analyst rating for Tristel?

Tristel currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TSTL will outperform the market and that investors should add to their positions of Tristel.
View the latest ratings for TSTL.

What other companies compete with Tristel?

Other companies that are similar to Tristel include BATM Advanced Communications, Advanced Medical Solutions Group, Verona Pharma plc (VRP.L), Bioventix and Instem. Learn More about companies similar to Tristel.

How do I contact Tristel's investor relations team?

Tristel's physical mailing address is Lynx Business Park,Fordham Road, SNAILWELL, CB8 7NY, United Kingdom. The company's listed phone number is +44-1638-721500. The official website for Tristel is www.tristel.com. Learn More about contacing Tristel investor relations.